AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2024
Sep 3, 2024
29875_dirs_2024-09-03_f41a957c-fb6b-4f58-9ef6-fe8dbacbeba2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2024-08-31
Reporting Person: Mandadi Tilak (EVP, Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-31 | Common Stock | F | 13097 | $57.24 | Disposed | 40414 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (RSU) | 49622 | Direct |
Footnotes
F1: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3